• Our Services
    • The Information Commons
    • Shifting the Research Paradigm
    • The Cancer Commons Difference
    • Our Approach
  • About Your Cancer
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Many Ways to Give
    • What Your Support Makes Possible
  • Our Services
    • The Information Commons
    • Shifting the Research Paradigm
    • The Cancer Commons Difference
    • Our Approach
  • About Your Cancer
    • Bladder Cancer
    • Brain Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Diffuse Midline Glioma
    • Esophageal Cancer
    • Kidney Cancer
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Melanoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Uterine Cancer
  • About Us
    • Our Story
    • Facing Advanced Cancer
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Testimonials
    • All Testimonials
  • Support Us
    • Many Ways to Give
    • What Your Support Makes Possible
 

Chronic Myelomonocytic Leukemia: 2022 Update on Diagnosis, Risk Stratification, and Management

July 13, 2022
Focus: Leukemia
Topics: Treatment Options

Written for oncology healthcare professionals, this article from the American Journal of Hematology covers the best new therapies for chronic myelomonocytic leukemia in 2022.

.

Tags: 5-azacitidine, chronic myelomonocytic leukemia, decitabine, stem cell transplant, TET2

Our Mission: Cancer Commons is a non-profit network of patients, physicians, scientists, and physicians united by a shared goal—to optimize each patient’s outcome and maximize collective learning to benefit the next patient.

Don’t miss Cancer Commons Connects
Insights and stories—from and for our community

Working.

Our Services

  • Care Navigation
  • Personalized Action Plans
  • Registering with Cancer Commons
  • Frequently Asked Questions (FAQ)

Perspectives

  • Latest Research
  • Treatment Options
  • Molecular Testing
  • Navigating Treatment
  • Living with Cancer
  • Patient Stories
  • Curious Dr. George
  • The Big Picture
  • Peer-Reviewed Publications

Organization

  • Our Story
  • Our Team
  • Our Core Values
  • Board of Directors
  • Partners
  • Expert Physician Advisors
  • Careers

About Us

  • News and Events
  • Financial Documents
  • Contact Us

Support & Giving

  • Contribute Now
  • Many Ways to Give
  • What Your Support Makes Possible
  • Testimonials


Donate

Cancer Commons
2625 Middlefield Road Suite 104
Palo Alto, CA 94306

650-289-4044

Patient Hotline

877-971-1200

  • Privacy Policy

© 2025 Cancer Commons.